REFERENCES
Almond, C.S.D. et al., 2012. Waiting list mortality among children listed for heart
transplantation in the United States. Circulation, 119(5), pp.717–727.
Badylak, S.F. et al., 2012. Engineered whole organs and complex tissues. The Lancet,
379(9819),
pp.943–952.
Available
at:
http://linkinghub.elsevier.com/retrieve/pii/S0140673612600737.
Badylak, S.F., Taylor, D. & Uygun, K., 2011. Whole-Organ Tissue Engineering:
Decellularization and Recellularization of Three-Dimensional Matrix Scaffolds.
Annual Review of Biomedical Engineering, 13(1), pp.27–53. Available at:
http://www.annualreviews.org/doi/abs/10.1146/annurev-bioeng-071910-124743.
Clarke, A. et al., 2014. Cost-effectiveness of left ventricular assist devices (LVADs) for
patients with advanced heart failure: Analysis of the British NHS bridge to
transplant (BTT) program. International Journal of Cardiology, 171(3), pp.338–345.
Available at: http://dx.doi.org/10.1016/j.ijcard.2013.12.015.
Crapo, P.M., Gilbert, T.W. & Badylak, S.F., 2011. An overview of tissue and whole
organ decellularization processes. Biomaterials, 32(12), pp.3233–43. Available at:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3084613&tool=pmcentr
ez&rendertype=abstract.
Gilbert, T., Sellaro, T. & Badylak, S., 2013. Decellularization of tissues and organs.
Biomaterials,
27,
pp.3675–3683.
Available
at:
http://linkinghub.elsevier.com/retrieve/pii/S0142961206001682.
Guethoff, S. et al., 2013. Ten-year results of a randomized trial comparing tacrolimus
versus cyclosporine a in combination with mycophenolate mofetil after heart
transplantation.
Transplantation,
95(4),
pp.629–34.
Available
at:
http://www.ncbi.nlm.nih.gov/pubmed/23423270 [Accessed October 21, 2015].
Heidenreich, P. a. et al., 2013. Forecasting the Impact of Heart Failure in the United
States: A Policy Statement From the American Heart Association. Circulation:
Heart
Failure,
6(3),
pp.606–619.
Available
at:
http://circheartfailure.ahajournals.org/cgi/doi/10.1161/HHF.0b013e318291329a.
13